ITEMS IN AFP WITH KEYWORD:
This review of commonly used weight-loss medications, including orlistat (Xenical), lorcaserin (Belviq), phentermine/topiramate (Qsymia), bupropion (Wellbutrin), metformin (Glucophage), and zonisamide (Zonegran), reported an average weight loss for participants of 2.5 to 8.0 kg (5.5 to 17.5 lb) rela...
This large, well-designed trial failed to find a statistically significant improvement in patient-oriented outcomes in patients with diabetes, despite a fairly intensive lifestyle intervention and long-term follow-up.
Obesity is increasingly common among pregnant women, and it can cause significant risk to mother and fetus. Family physicians who provide prenatal care should also be familiar with recommendations for the management of obesity in pregnancy.
Case study: A 40-year-old woman presents to your office for a routine well-woman examination. She has no significant medical history. She recently participated in a health fair at work and underwent free lipid and glucose screening; both levels were within normal limits.
Nov 15, 2012 Issue
Screening for and Management of Obesity in Adults: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends screening all adults for obesity. Clinicians should offer or refer patients with a body mass index (BMI) of 30 kg per m2 or higher to intensive, multicomponent behavioral interventions.
Overall, children up to 12 years of age benefited from school-based obesity prevention interventions; this effect was not demonstrated among adolescents 13 years and older. Although the overall effect size was small, interventions that promoted physical activity, alone or in combination with diet, w...
Bariatric surgery procedures, including laparoscopic adjustable gastric banding, laparoscopic sleeve gastrectomy, and Roux-en-Y gastric bypass, result in an average weight loss of 50 percent of excess body weight. Remission of diabetes mellitus occurs in approximately 80 percent of patients after Ro...
There is little evidence about secondary causes of obesity in adults. The evaluation for secondary causes of obesity should include a patient history and physical examination, with additional laboratory testing based on specific symptoms, risk factors, and index of suspicion.
Phentermine and diethylpropion are appetite suppressants approved for use in the United States as adjuncts in the treatment of obesity. These agents demonstrate a modest weight loss benefit when combined with dietary modifications and exercise.
Mar 15, 2011 Issue
Screening for Obesity in Children and Adolescents: Recommendation Statement [U.S. Preventive Services Task Force]
The U.S. Preventive Services Task Force (USPSTF) recommends that clinicians screen children six years and older for obesity, and offer them or refer them to comprehensive, intensive behavioral interventions to promote improvement in weight status.